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1. Introduction 
Calmodulin is a small, acidic, intracellular calcium- 
binding protein which has been shown to influence 
the activity of a number of enzymic and structural 
systems in a calcium dependent manner (review [ 11). 
The protein, which is apparently ubiquitous in euka- 
ryotes, has been implicated as one of the principal 
intracellular targets for the calcium released intracel- 
lularly following various external stimuli. Of the 
various probes used to study the role of calmodulin 
one of the more useful has been the class of anti- 
psychotic drugs the phenothiazines which are able to 
bind to calmodulin in the presence of calcium, and 
block its modulating activity [2]. The specificity of 
the interaction of the various phenothiazines with cal- 
modulin and the pharmacological significance of the 
interaction have been the subject of debate [3-S]. 
eluting from the column at -0.3-0.35 M NaCl in_ 
20 mM Tris-HCl, 15 mM 2-mercaptoethanol, 1 mM 
EDTA (pH 7.8) was adjusted to a total concentration 
of 2 mM CaCla by addition of 1 /Sooth vol. 1 M CaClz 
to give -1 mM free Ca’+ion. The pool was then applied 
directly to a column (2.5 X 2dcm) of fluphenazine- 
Sepharose (prepared as in [7]) equilibrated in 50 mM 
imidazole, 200 mM NaCl, 1 mM CaCl,, 15 mM 2-mer- 
captoethanol (pH 7.2). Unbound material was washed 
from the column with 500 ml of this buffer, and the 
calmodulin then eluted with 300 ml of the same 
buffer but containing 5 mM EGTA in place of CaC12. 
Fractions (9 ml) were collected and the eluate moni- 
tored for calmodulin by alkaline urea slab-gel electro- 
phoresis of samples from every tube. The calmodulin 
containing eluate was pooled, dialyzed against 2 
changes of 50 vol. each of 2 mM Tris-HCl 15 mM 2- 
mercaptoethanol (pH 7.8) and lyophilized. 
Here we have attempted to identify sites of inter- 
action of phenothiazines on calmodulin using affinity 
chromatography of cyanogen bromide fragments of 
the molecule on fluphenazine-Sepharose. 
2. Materials and methods 
Fluphenazine was kindly given by Squibb and Sons 
(Princeton NJ). Other chemicals and reagents were 
laboratory reagent grade obtained through local sup- 
pliers. Bovine brains were obtained from Trelegan 
(Cambridge MA). 
Calmodulin prepared by this method was single 
banded on SDS and alkaline urea gel electrophoresis 
and had full biological activity as judged by activation 
of calmodulindependent phosphodiesterase. The 
whole preparative routine takes <5 days, including 
dialysis and lyophilization, and yields -110 mg cal- 
modulin/kg brain. The purified calmodulin contains 
none of the 7000 M, phenothiazine-binding protein 
described in [ 81. 
2.2. oanogen bromide cleavage 
2 .l . Calmodulin preparation 
A calmodulin containing fraction was obtained 
from bovine brain by ionexchange chromatography 
on DEAE-cellulose essentially as in [6]. The material 
Lyophilized calmodulin (5 mg) were dissolved in 
0.5 ml 70% formic acid. Cleavage was begun by adding 
10~1 of a 1 glml solution ofCNBr in acetonitrile.The 
solution was incubated at 25°C for 24 h after which 
it was evaporated to dryness under a stream ofnitrogen. 
The dried residue pas resuspended in 200 ~1 Hz0 and 
1 M ammonium hydroxide solution added until the 
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residue completely dissolved. The solution was again 
evaporated to dryness under a stream of N2. 
2.3. Chromatography of CNBr fragments on j7u- 
phenazine-Sepharose 
The dried residue of CNBr fragments was redis- 
solved in 2 ml 50 mM imidazole, 200 n&l NaCI, 
1 mM CaC&, 15 mM 2-mercaptoethanol (pH 7.2) and 
applied to a column (1.5 X 7 cm) of fluphenazine- 
Sepharose equilibrated in the same buffer. Unbound 
material was washed from the column with 200 ml 
buffer. The column was then eluted with 50 ml of the 
same buffer containing 5 n&l EGTA in place of cal- 
cium. Fractions (5 ml) were collected throughout 
sample application, washing and elution. The eluate 
was monitored by running 16% acrylamide alkaline 
urea gel electrophoresis of samples from each tube. 
2 4. Phosphodiesterase assay 
Bovine brain, calmodulin-activatable, phosphodi- 
esterase, prepared as in [6], was assayed using the 
method in [9]. Enzymic activity was determined at 
37°C in 5 PM cyclic AMP, 0.1 mM CaCl, and in the 
presence or absence of calmodulin or the fluphenazine 
binding fragment. 
2.5. Electrophoresis 
SDS gel electrophoresis was carried out using 15% 
polyacrylamide gels and the buffer system in [lo]. 
Alkaline gel electrophoresis was carried out using 
16% polyacrylamide gels containing 6 M urea and a 
continuous buffer system of 25 mM Tris-80 mM 
glycine (pH 8.6) as in [ 111. 
2.6. Amino acid analysis 
Amino acid analysis was performed on samples 
hydrolyzed in 6 N HCl for 24 h at 110°C. Analyses 
were determined using a Beckman 119C 1 analyzer 
with 126 data system. A column (0.6 X 24 cm) of 
W3 resin was used with the Beckman buffer system 
for collagen. 
2.7. Sequence analysis 
The sequence of the N-terminal end of the pheno- 
thiazine-binding fragment was determined by auto- 
mated Edman degradation using a Beckman 890C 
sequencer equipped with a cold trap and a modifica- 
tion of program 121078 with 0.25 M Quadrol and a 
combined Sr and SZ wash. Phenylthiohydantoin deriv- 
atives of amino acids were determined by high-pres- 
sure liquid chromatography. 
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3. Results 
Cyanogen bromide fragmentation of calmodulin 
produces peptides which can be visualized by electro- 
phoresis on 16% polyacrylamide alkaline urea gel 
electrophoresis (fig.la). This band pattern, obtained 
consistently, is characteristic for cyanogen bromide 
fragments of bovine brain calmodulin. When the frag- 
ments are applied to a column of fluphenazine- 
Sepharose in the presence of calcium the unbound 
material shows one band less than the characteristic 
pattern on electrophoresis (fig.lb). If the column is 
eluted with buffer containing 5 mM EGTA in place of 
calcium then the eluate is found to contain a peptide 
which migrates at a position corresponding to the 
band missing from the unbound material (fig.lc). 
This peptide migrates as a single band on SDS gel 
electrophoresis having an app. Mr-value close to that 
of bovine lung aprotinin (M, 6500) (fig.le). 
The amino acid sequence of the N-terminal end of 
the fragment corresponds to the region of calmodulin 
extending from residue 77 (table 1). The total amino 
acid analysis of the fragment is shown in table 2. 
Comparison of this analysis with the analyses of the 
individual cyanogen bromide fragments, as determined 
in [ 121 shows no similarity. However, a sum of the 
analyses of equimolar amounts of CNBr 1A and CNBr 
1 B, using the designations in [ 121, closely corresponds 
to the values for the fluphenazine-binding fragment 
Fig.1. Alkaline urea and SDS gels of bovine brain calmodulin 
and its cyanogen bromide fragments: (a-d) 16% acrylamide 
alkaline urea gels; (e,f) 15% acrylamide SDS gels; (a) 50 ccg 
cyanogen bromide fragments before application to fluphen- 
azine-Sepharose column; (b) 50 pg unbound cyanogen 
bromide fragments from fluphenazine-Sepharose column; 
(c) 5 pg cyanogen bromide fragment eluted from fluphen- 
azine-Sepharose column by EGTA; (d) 5 pg bovine brain 
calmodutin; (e) as (c) but on SDS gel;(f) 5 pg bovine brain 
calmodulin plus 5 c(g bovine lung aprotinin (Mr 6500). 
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N-terminal sequence of the phenothiazine binding fragment 
of calmodulin determined by automated Edman degradation 
Table 1 Table 2 
Amino acid analysis of fluphenazine binding fragment and 
CNBr lA-1B 
Ammo Residue number in Step of fragment Yield 





Lys 77 1 12.2 
Asp 78 2 11.0 
Thr 79 3 1.3 
Asp 80 4 7.6 
Sera 81 5 n.d. 
Glu 82 6 9.8 
GlU 83 7 13.4 
Glu 84 8 16.1 
Be 85 9 20.4 
Arg 86 10 6.8 
a Yields of this residue were insufficient to enable adequate 
determination 
(table 2). These two fragments are contiguous in the 
sequence of calmodulin (residues 77-124) and are 
connected by a Metlog-Thrrre bond. Met-Thr bonds 
have been reported as often undergoing incomplete 
cleavage, the methionine being converted into homo- 
serine without breaking the peptide bond [ 131. Since 
the fluphenazine binding peptide migrates as a single 
band on electrophoresis we tentatively designate the 
fragment as corresponding to lA-1B in which the 
Met-Thr bond has not been cleaved. The existence 
of such a fragment in cyanogen bromide digests of 
calmodulin has been reported in [12,14,15]. 
Asx 8.4 8 
Thr 2.5 3 
Ser 1.3 2 
Glx 9.8 9 
Pro 0 0 
Gly 3.8 3 
Ala 3.3 3 
Val 3.6 3 
Ileu 2.9 2 
Leu 2.4 3 
Tyr 1.0 1 
Phe 2.3 2 
TmlC 0.7 1 
LYS 1.6 2 
His 0.7 1 
Arg 2.9 3 
Hsrd 1.4 2 
a Mol/mol5500 Mr peptide 
b Fragment designation and analysis according to [ 121 
c Trimethyllysine 
d Determined as homoserine and homoserine lactone 
M,-values of small peptides and their mobility on SDS 
gels have been reported [lo]. 
The fluphenazine binding fragment does not acti- 
vate the calmodulindependent phosphodiesterase of 
bovine brain when included in enzyme assays in 
amounts in lo-fold molar excess over the amount of 
native calmodulin required to produce maximal activa- 
tion . 
4. Summary and discussion 
The specific residues in the fragment involved in 
binding to fluphenazine remain to be determined. 
Phenothiazines may interact with calmodulin in a 
non-specific manner dependent only on hydrophobic 
interactions [ 3,4]. The calcium-induced exposure of 
hydrophobic regions on calmodulin and other calcium- 
binding proteins has been reported [16,17]. The 
lA-1B fragment may therefore contain such a region. 
The specificity of this site for phenothiazines and 
other calmodulin interacting drugs will be the subject 
of further study. 
We have isolated a cyanogen bromide fragment 
from bovine brain calmodulin which is able to bind to 
fluphenazine-Sepharose in a calcium-dependent 
manner. We have tentatively designated this fragment 
as corresponding to CNBr lA-CNBr 1B in which the 
Met ros-ThrlIo bond has not been cleaved. The cal- 
culated Mr of this peptide (5500) is slightly lower 
than might be judged from its mobility on SDS gel 
electrophoresis in comparison to bovine lung aprotinin, 
however, anomalies in the relationship between the 
The inability of the fluphenazine-binding fragment 
to activate phosphodiesterase may suggest hat activa- 
tion is a property of either the whole calmodulin 
molecule, or of a region remote from lA-1B. How- 
ever, it has been suggested that Metros may be one of 
the sites of oxidation by IV-chlorosuccinimide which 
leads to the loss of biological activity of calmodulin 
[ 181. The conversion to Metros to homoserine by 
cyanogen bromide while not cleaving the fragment 
may therefore inactivate an otherwise active region of 
the molecule. For this reason it is not possible from 
73 
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these results to preclude this section of the molecule 
as a site of interaction between calmodulin and phos- 
phodiesterase. However, tryptic peptides encompassing 
this region of calmodulin have also been reported to 
have little phosphodiesterase activating ability [ 191. 
Further studies of the fluphenazine-binding frag- 
ment should enable us to define the nature of the 
interaction of phenothiazines at this region of the cal- 
modulin molecule and lead to an improved under- 
standing of the mode of action of these drugs in 
blocking calmodulin function. 
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